ResMed Inc. (LON:0KW4)
London flag London · Delayed Price · Currency is GBP · Price in USD
243.34
-2.34 (-0.95%)
At close: May 9, 2025

ResMed Revenue

ResMed had revenue of $1.29B USD in the quarter ending March 31, 2025, with 7.92% growth. This brings the company's revenue in the last twelve months to $5.02B, up 9.54% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.

Revenue (ttm)
$5.02B
Revenue Growth
+9.54%
P/S Ratio
7.07
Revenue / Employee
$503.16K
Employees
9,980
Market Cap
27.49B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 20202.96B350.44M13.44%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Genus 671.60M
Revenue Rankings